Taken together, these data suggest that in the absence of eNOS, RBC NOX4 is a source of elevated ROS, such that RBC eNOS-derived NO bioactivity is crucial in preventing an overabundance of, in part, RBC NOX4-dependent ROS production, and in turn, endothelial dysfunction. This evidence concerns the gene NOS3 and endothelial dysfunction.